Live Markets
Tuesday, October 27, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

GCAN (GCAN)

Drug Manufacturers - Specialty & Generic

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
—
P/E (TTM)
0.23
EPS
$7.05
Div Yield
—
52W Range
$0.18–$3.36
Beta
0.30

Company overview

Live quote temporarily unavailable — press releases and news are still shown below.

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

1 employeeswww.gcanrx.com

Peers in Healthcare

GCAN has no peer companies in this window.

Recent press releases

GCAN has not issued a press release in this window.

SEC filings

All filings →

GCAN has not filed an SEC document in this window.

GCAN has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for GCAN in this window.

People at GCAN

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
—
NI -$103.5K
06/25
—
NI -$390.9K
09/25
—
NI -$36.1K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.04
Prior: $0.00
Revenue sparkline